Fiera Capital (Canada)
EIDX

Fiera Capital (Canada)’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Fiera Capital (Canada)’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-44,158
Closed -$2.53M – 714
2019
Q4 		$2.53M Sell
44,158
-32,042
-42% -$1.59M 0.01% 329
2019
Q3 		$2.74M Sell
76,200
-10,016
-12% -$391K 0.01% 302
2019
Q2 		$2.68M Sell
86,216
-4,380
-5% -$119K 0.01% 340
2019
Q1 		$2.12M Sell
90,596
-41,155
-31% -$660K 0.01% 379
2018
Q4 		$1.81M Buy
+131,751
New +$1.66M 0.01% 403

Other funds holding EIDX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fiera Capital (Canada)'s EIDX Position: Q1 2020 in Review

Fiera Capital (Canada) sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2020, closing a stake of 44,158 shares — an estimated $2.53M sold.

Fiera Capital (Canada) first reported a position in EIDX in Q4 2018 and held it in 5 quarters. The position peaked at $2.74M in Q3 2019. 89 funds tracked by Wall St. Rank hold EIDX as of Q1 2020.

  • Fiera Capital (Canada) reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Fiera Capital (Canada) sold 44,158 Eidos Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $2.53M.
  • Fiera Capital (Canada) first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2018 and held it in 5 quarters.
  • Fiera Capital (Canada)'s Eidos Therapeutics, Inc. Common Stock position peaked at $2.74M in Q3 2019.
  • 89 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Fiera Capital (Canada)'s 13F filing for Q1 2020, filed 8 May 2020.